Literature DB >> 6294237

Selective blockade of brain alpha 2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine.

N E Andén, K Pauksens, K Svensson.   

Abstract

The motor activity of groups of three mice was increased by yohimbine at doses up to 3 mg/kg intraperitoneally. The turnover of dopamine and noradrenaline in the mouse brain, as assessed by the disappearance of catecholamines following treatment with the tyrosine hydroxylase inhibitor alpha-methyltyrosine, was accelerated by yohimbine with a peak effect after 10 mg/kg intraperitoneally. Prazosin (3 mg/kg i.p.) completely antagonized the stimulatory effect of yohimbine on motor activity and on dopamine turnover but it somewhat potentiated the stimulatory effect on the turnover of noradrenaline. Amphetamine reversed the prazosin-induced hypomotility, indicating that prazosin can selectively block postsynaptic alpha 1-receptors. Yohimbine did not stimulate motor activity following 10 mg/kg and it retarded the turnover of dopamine following 30 mg/kg. These actions might be due to blockade of postsynaptic alpha-receptors by yohimbine. The data indicate that yohimbine at low doses stimulates motor activity and dopamine turnover by selectively blocking alpha 2-autoreceptors leading to increased release of noradrenaline and subsequent activation of post-synaptic alpha 1-receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294237     DOI: 10.1007/bf01243754

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  16 in total

1.  R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.

Authors:  N E Andén; C Gomes; B Persson; G Trolin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

2.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.

Authors:  N E Andén; T H Svensson
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

5.  Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.

Authors:  G Engström; T H Svensson; B Waldeck
Journal:  Brain Res       Date:  1974-09-13       Impact factor: 3.252

6.  Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.

Authors:  N E Andén; U Strömbom; T H Svensson
Journal:  Psychopharmacologia       Date:  1973

7.  On the role of brain catecholamines in motor activity: experiments with inhibitors of synthesis and of monoamine oxidase.

Authors:  T H Svensson; B Waldeck
Journal:  Psychopharmacologia       Date:  1970

8.  Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography.

Authors:  L J Felice; J D Felice; P T Kissinger
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

9.  Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain.

Authors:  D B Menkes; J M Baraban; G K Aghajanian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

10.  Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.

Authors:  N E Andén; U Strömbom; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

View more
  16 in total

1.  Alpha(1)-adrenergic and alpha(2)-adrenergic balance in the dorsal pons and gross behavioral activity of mice in a novel environment.

Authors:  Eric A Stone; Yan Lin; Mohammad R Ahsan; David Quartermain
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

Review 2.  Rate-dependent behavioral effects of stimulation of central motoric alpha(1)-adrenoceptors: hypothesized relation to depolarization blockade.

Authors:  Eric A Stone; David Quartermain
Journal:  Psychopharmacology (Berl)       Date:  2005-01-12       Impact factor: 4.530

3.  Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.

Authors:  S L Dickinson; B Gadie; I F Tulloch
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Thyroid hormone and norepinephrine: effects on alpha-2, beta, and reuptake sites in cerebral cortex and heart.

Authors:  A C Swann
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Bidirectional pharmacological perturbations of the noradrenergic system differentially affect tactile detection.

Authors:  Jim McBurney-Lin; Yina Sun; Lucas S Tortorelli; Quynh Anh T Nguyen; Sachiko Haga-Yamanaka; Hongdian Yang
Journal:  Neuropharmacology       Date:  2020-05-21       Impact factor: 5.250

8.  The pharmacology of fluparoxan: a selective alpha 2-adrenoceptor antagonist.

Authors:  C A Halliday; B J Jones; M Skingle; D M Walsh; H Wise; M B Tyers
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

9.  Catecholamine synthesis and metabolism in the central nervous system of mice lacking alpha-adrenoceptor subtypes.

Authors:  M A Vieira-Coelho; M P Serrão; J Afonso; C E Pinto; E Moura
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

10.  Formation of deaminated metabolites of dopamine in noradrenaline neurons.

Authors:  N E Andén; M Grabowska-Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.